Home/miRoncol/Hai Hu, PhD

HH

Hai Hu, PhD

Co‑Founder & Chief Scientific Officer

Therapeutic Areas

miRoncol Pipeline

Drug	Indication	Phase
Real-time Multi-Cancer Early Risk Assessment	Solid Tumors (12+ common types)	Preclinical

Leadership Team at miRoncol

Co‑Founder & Chief Executive Officer

Christopher M. Gallagher, MD

Co‑Founder & Chief Medical Officer

Gilles Erb, PhD

Medical & Scientific Director

View full miRoncol profile